I have been examining Catalyst Pharma for quite some time now and I believe there is substantial upside to with their products. I suspect a price target in the $1.75 to $2.50 by year end.
Intel is preparing for a breakout of the upward trending channel. Previous gap fill and moving average crossovers indicate to me a push towards $22.00 as their earnings are released on 4/16/2013.
My Price Target is set long at $24.00
Dollar Tree is forming a bullish cup and handle pattern with what I project is a 20% upside potential. My price target is set at $50.00. The entry point can be seen at the Fib Ret. level of 38.2% channeling the "handle" part of the pattern.